CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 148 enrolled
Drug / intervention
supportan +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00488904
NCT00488904Phase 4Completed
CompareCT.gov

Omega-3 Fatty Acids and Postoperative Complication After Colorectal Surgery

Aalborg University Hospital·interventional·Posted Jun 20, 2007·Updated Apr 12, 2010

In Brief

A Phase 4 clinical trial evaluating supportan and supportan placebo for Colorectal Cancer. Completed, enrolled 148 participants across 1 site.

Detailed Summary

To discover whether an Omega-3 fatty acid (eicosapentaenoic acid/EPA and docosahexaensyre/DHA) enriched nutritional supplement given 7 days preoperatively and 7 days postoperatively may reduce the frequency of postoperative infectious complications defined as: pneumonia, wound infection, urinary tract infection, peritonitis (including anastomotic leakage) and septic conditions of any cause in patients who undergo elective operations for colorectal cancer compared with a nutritional preparation that is identical apart from the EPA content.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColorectal Cancer
CountriesDenmark
Collaborators--

Timeline

Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 20, 2007
Enrollment StartJun 1, 2007
Primary CompletionJan 1, 2010
Study CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 19.0 years ago

Interventions

supportandietary

2 sip feed pr. day

supportan placebodietary

2 sip feed pr. day